# Do generalized epilepsies exhibit more attentional or executive disorders?

**Authors:** Bertille Lacour, Vincent Heintz, Natacha Forthoffer, Serge Chassagnon, Alain Jager, Louis Maillard, Helene Brissart

PMC · DOI: 10.1016/j.ebr.2025.100843 · Epilepsy & Behavior Reports · 2025-12-24

## TL;DR

This study finds that patients with genetic generalized epilepsy often have attention and executive function issues, with divided attention and mental flexibility being most affected.

## Contribution

The study identifies distinct cognitive profiles in GGE patients and emphasizes the importance of assessing divided attention for accurate cognitive evaluation.

## Key findings

- Divided attention is the most impaired function in 44.93% of GGE patients and reflects working memory deficits.
- Mental flexibility is the most affected executive function in 39.68% of patients.
- Cognitive performance is weakly influenced by clinical and psychosocial factors, but anxiety and depression correlate with poorer divided attention.

## Abstract

•Attentional and executive deficits each affect ∼ 60 % of GGE patients.•Divided attention is the most impaired function and a marker of working memory.•Mental flexibility is the most affected executive component (40% of patients).•Multidimensional testing reveals distinct cognitive profiles in GGE.•Incorporating divided attention tasks improves cognitive assessment accuracy.

Attentional and executive deficits each affect ∼ 60 % of GGE patients.

Divided attention is the most impaired function and a marker of working memory.

Mental flexibility is the most affected executive component (40% of patients).

Multidimensional testing reveals distinct cognitive profiles in GGE.

Incorporating divided attention tasks improves cognitive assessment accuracy.

This study aimed to characterize attentional and executive dysfunctions in patients with genetic generalized epilepsies (GGE), using specific and validated neuropsychological tools. Secondary objectives included estimating the prevalence of cognitive impairments and exploring potential clinical and psychosocial determinants. A total of 69 adult patients with GGE were enrolled in this multicentric observational study. Participants completed screening questionnaires for anxiety and depression and underwent a battery of neuropsychological tests assessing four attentional components (alertness, sustained, selective, and divided attention), executive functions (flexibility, inhibition, verbal initiation and auditory working memory). Attentional and executive impairments were highly prevalent, affecting approximately 60–64 % of the cohort. Divided attention was the most frequently impaired attentional component (44.93 %), while mental flexibility was the most commonly affected executive function (39.68 %). Selective and sustained attention were relatively preserved. Working memory manipulation was impaired in 17.4 % of patients. Cognitive performance was weakly influenced by clinical and psychosocial factors. Anxiety or depression was associated with poorer divided attention, epilepsy duration with lower selective attention, and education and number of anti-seizure medications with better performance across selective, sustained, and executive attention domains. These findings highlight the need for targeted neuropsychological assessments in GGE, prioritizing divided attention and flexibility. Since divided attention reflects both attentional control and working memory interventions focusing on working memory may offer greater clinic utility. Given the scarcity of studies on cognition rehabilitation in epilepsy, further research is needed, particularly on divided attention as a potential cognitive remediation target.

## Linked entities

- **Diseases:** anxiety (MONDO:0005618), depression (MONDO:0002050)

## Full-text entities

- **Diseases:** idiopathic generalized epilepsies (MESH:C562694), Anxiety (MESH:D001007), ILAE (MESH:C537134), psychiatric (MESH:D001523), impaired (MESH:D060825), resistant epilepsy (MESH:D000069279), fatigue (MESH:D005221), neurological diseases (MESH:D020271), developmental and epileptic encephalopathies (MESH:C562695), executive disorders (MESH:D009358), Neurological Disorders (MESH:D009461), impaired component of attention (MESH:C566443), seizure (MESH:D012640), epileptic encephalopathies (MESH:D001927), GAD-7 (MESH:C000726808), reduced psychomotor speed (MESH:D011596), sustained (MESH:D009120), Epilepsy (MESH:D004827), JME (MESH:D020190), Attentional and executive impairments (MESH:D001289), executive dysfunction (MESH:D006331), Drug (MESH:D000081015), Depression (MESH:D003866), EEM (MESH:D005141), cognitive deficits (MESH:D003072), GGE (MESH:D004829), Manipulation in auditory WM (MESH:D008569), CAE (MESH:D004832)
- **Chemicals:** clobazam (MESH:D000078306), brivaracetam (MESH:C482793), eslicarbazepine acetate (MESH:C416835), ASM (-), valproate (MESH:D014635), zonisamide (MESH:D000078305), lamotrigine (MESH:D000077213), carbamazepine (MESH:D002220), lacosamide (MESH:D000078334), levetiracetam (MESH:D000077287), topiramate (MESH:D000077236), alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950469/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950469/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950469/full.md

---
Source: https://tomesphere.com/paper/PMC12950469